RLAY
Relay Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.84
−1.82%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 402.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.64x
- Price / sales
- 398.90x
- Price / cash flow
- -19.46x
Enterprise value
- Enterprise value
- $3.2B
- EV / sales
- 313.85x
- EV / EBITDA
- -11.32x
- EV / EBIT
- -10.46x
- Market cap
- $4.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026